Erratum: Therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma(International Journal of Oncology(2018)53(2627-2636)DOI: 10.3892/ijo.2018.4585)

Jorge De La Chapa, Prajjal Kanti Singha, McKay Sallaway, Kristen Self, Ranna Nasreldin, Ramesh Dasari, Matthew Hart, Alexander Kornienko, Jeremy Just, Jason A. Smith, Alex C. Bissember, Cara B. Gonzales

Research output: Contribution to journalComment/debate

Abstract

After the publication of the above article, the authors have realized that they failed to properly acknowledge the work performed by their Center for Innovative Drug Discovery High Throughput Screening Core Facility in the paper. The Declarations section of their paper should therefore have also included the following statement: "The UT Health San Antonio Center for Innovative Drug Discovery HTS Facility was funded in part by the Cancer Prevention Research Institute of Texas (CPRIT; grant no. RP160844)".

Original languageEnglish (US)
Pages (from-to)1045
Number of pages1
JournalInternational journal of oncology
Volume56
Issue number4
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Erratum: Therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma(International Journal of Oncology(2018)53(2627-2636)DOI: 10.3892/ijo.2018.4585)'. Together they form a unique fingerprint.

Cite this